Anteneh Tesfaye

4PUBLICATIONS
26CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 12, 2021
Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer.

Jonathan M Loree, Yucai Wang, Muddassir A Syed

|Feb 11, 2021
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer.

Arta M Monjazeb, Anita Giobbie-Hurder, Ana Lako

|Dec 14, 2019
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma.

Asfar S Azmi, Husain Yar Khan, Irfana Muqbil

|Dec 20, 2017
The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.

Anteneh A Tesfaye, Mandana Kamgar, Asfar Azmi

Pageof 1